Abstract Treatment for inflammatory bowel disease (IBD) is challenging since current anti-
inflammatory and immunosuppressive therapies do not address the underlying causes of …

Autoimmunity, allergy, and transplant rejection are a collection of chronic diseases that are
currently incurable, drastically decrease patient quality of life, and consume considerable …

Depletion of beneficial microbes by modern lifestyle factors correlates with the rising
prevalence of food allergies. Re-introduction of allergy-protective bacteria may be an …

Food allergy is a growing public health issue among children and adults that can lead to life-
threatening anaphylaxis following allergen exposure. The criterion standard for disease …

Recent advancements in genomics, transcriptomics, and metabolomics have significantly
advanced our understanding of the human gut microbiome and its impact on the efficacy …

Current therapies primarily targeting inflammation often fail to address the root relationship
between intestinal mucosal integrity and the resulting dysregulated cell death and ensuing …

The objective of this investigation was to appraise the mitigative effects of Lonicera caerulea
pomace (LCP)-supplemented diets on Dextran Sulfate Sodium (DSS)-induced colitis, and to …

Short chain fatty acid (SCFAs), such as butyrate, have shown promising therapeutic potential
due to their immunomodulatory effects, particularly in maintaining immune homeostasis …

Xylooligosaccharides (XOSs) have recently garnered interest for their potential as an anti-
constipation agent. In this study, we investigated the effects of XOSs derived from corn cobs …

The only FDA-approved oral immunotherapy for a food allergy provides protection against
accidental exposure to peanuts. However, this therapy often causes discomfort or side …